Pro-Oxidant Activity of Protocatechuic Acid Alkyl Esters
6. Gandhy SU, Kim K, Larsen L, Rosengren RJ, Safe S (2012) Curcumin and
synthetic analogs induce reactive oxygen species and decreases specificity protein
(Sp) transcription factors by targeting microRNAs. BMC Cancer 12: 564–576.
7. Porter NA (2013) A perspective on free radical autoxidation: the physical organic
chemistry of polyunsaturated fatty acid and sterol peroxidation. J Org Chem 78:
3511–3524.
25. Kagan VE, Kuzmenko AI, Tyurina YY, Shvedova AA, Matsura T, et al. (2001)
Pro-oxidant and antioxidant mechanisms of etoposide in HL-60 cells: role of
myeloperoxidase. Cancer Res. 61: 7777–7784.
26. Tafazoli S, Wright JS, O’Brien PJ (2005) Prooxidant and antioxidant activity of
vitamin E analogues and troglitazone. Chem Res Toxicol 18: 1567–1574.
´
27. Nu´n˜ez-Delicado E, Sa´nchez-Ferrer A, Garcıa-Carmona F (1997) A kinetic study
of the one-electron oxidation of Trolox C by the hydroperoxidase activity of
lipoxygenase. Biochim Biophys Acta 1335: 127–134.
28. Thomas MJ, Bielski BHJ (1989) Oxidation and reaction of trolox c, a tocopherol
analog, in aqueous solution. A pulse-radiolysis study. J Am Chem Soc 111:
3315–3319.
8. Russell LHJr, Mazzio E, Batista RB, Zhu ZP, Agharahimi M, et al. (2012)
Autoxidation of gallic acid induces ROS-dependent death in human prostate
cancer LNCaP cells. Anticancer Res 32: 1595–1602.
9. Metzler M, Pfeiffer E, Schulz SI, Dempe JS (2013) Curcumin uptake and
metabolism. Biofactors 39: 14–20.
29. Zou L, Xu Y, Luo P, Zhang S, Ye B (2012) Electrochemical detection of
dihydromyricetin using a DNA immobilized ethylenediamine/polyglutamic
modified electrode. Analyst 137: 414–419.
30. Galati G, Sabzevari O, Wilson JX, O’Brien PJ (2002) Prooxidant activity and
cellular effects of the phenoxyl radicals of dietary flavonoids and other
polyphenolics. Toxicology 177: 91–104.
10. Murias M, Ja¨ger W, Handler N, Erker T, Horvath Z, et al. (2005) Antioxidant,
prooxidant and cytotoxic activity of hydroxylated resveratrol analogues:
structure-activity relationship. Biochem Pharmacol 69: 903–912.
11. Ligeret H, Barthelemy S, Zini R, Tillement JP, Labidalle S, et al. (2004) Effects
of curcumin and curcumin derivatives on mitochondrial permeability transition
pore. Free Radic Biol Med 36: 919–929.
´
´
´
´
´
´
31. Hadzi-Taskovic Sukalovic V, Vuletic M, Vucinic Z, Veljovic-Jovanovic S (2008)
Effectiveness of phenoxyl radicals generated by peroxidase/H2O2-catalyzed
oxidation of caffeate, ferulate, and p-coumarate in cooxidation of ascorbate and
NADH. J Plant Res 121: 115–123.
´
12. Locatelli C, Rosso R, Santos-Silva MC, de Souza CA, Licınio MA, et al. (2008)
Ester derivatives of gallic acid with potential toxicity toward L1210 leukemia
cells. Bioorg Med Chem 16: 3791–3799.
13. Park WH, Kim SH (2013) MAPK inhibitors augment gallic acid-induced A549
lung cancer cell death through the enhancement of glutathione depletion. Oncol
Rep 30: 513–519.
32. Ximenes VF, Kanegae MP, Rissato SR, Galhiane MS (2007) The oxidation of
apocynin catalyzed by myeloperoxidase: proposal for NADPH oxidase
inhibition. Arch Biochem Biophys 457: 134–141.
14. Cavaliere V, Papademetrio DL, Lombardo T, Costantino SN, Blanco GA, et al.
(2014) Caffeic acid phenylethyl ester and MG132, two novel nonconventional
chemotherapeutic agents, induce apoptosis of human leukemic cells by
disrupting mitochondrial function. Target Oncol 9: 25–42.
33. Ghosh A, Kanthasamy A, Joseph J, Anantharam V, Srivastava P, et al. (2012)
Anti-inflammatory and neuroprotective effects of an orally active apocynin
derivative in pre-clinical models of Parkinson’s disease. J Neuroinflammation 9:
241–257.
15. Fan GJ, Jin XL, Qian YP, Wang Q, Yang RT, et al. (2009) Hydroxycinnamic
acids as DNA-cleaving agents in the presence of Cu (II) ions: mechanism,
structure-activity relationship, and biological implications. Chem Eur J 15:
12889–12899.
34. Simonyi A, Serfozo P, Lehmidi TM, Cui J, Gu Z, et al. (2012) The
neuroprotective effects of apocynin. Front Biosci 4: 2183–2193.
35. Senejoux F, Girard-Thernier C, Berthelot A, Be´valot F, Demougeot C (2013)
New insights into the mechanisms of the vasorelaxant effects of apocynin in rat
thoracic aorta. Fundam Clin Pharmacol 27: 262–270.
36. Wondrak GT (2009) Redox-Directed Cancer Therapeutics: Molecular Mech-
anisms and Opportunities. Antioxid Redox Signal 11: 3013–3069.
37. Chan T, Galati G, O’Brien PJ (1999) Oxygen activation during peroxidase
catalysed metabolism of flavones or flavanones. Chem Biol Interact 122: 15–25.
38. Petroˆnio MS, Zeraik ML, Fonseca LM, Ximenes VF (2013) Apocynin: Chemical
and Biophysical Properties of a NADPH Oxidase Inhibitor. Molecules 18: 2821–
2839.
39. Galato D, Ckless K, Susin MF, Giacomelli C, Ribeiro-do-Valle RM, et al. (2001)
Antioxidant capacity of phenolic and related compounds: correlation among
electrochemical, visible spectroscopy methods and structure-antioxidant activity.
Redox Rep 6: 243–250.
40. Gunckel S, Santander P, Cordano G, Ferreira J, Munoz S, et al. (1998)
Antioxidant activity of gallates: an electrochemical study in aqueous media.
Chem Biol Interact 114: 45–59.
16. Lende AB, Kshirsagar AD, Deshpande AD, Muley MM, Patil RR, et al. (2011)
Anti-inflammatory and analgesic activity of protocatechuic acid in rats and mice.
Inflammopharmacology 19: 255–263.
17. de Faria CM, Nazare´ AC, Petroˆnio MS, Paracatu LC, Zeraik ML, et al. (2012)
Protocatechuic acid alkyl esters: hydrophobicity as a determinant factor for
inhibition of NADPH oxidase. Curr Med Chem 19: 4885–4893.
18. Reis B, Martins M, Barreto B, Milhazes N, Garrido EM, et al. (2010) Structure-
property-activity relationship of phenolic acids and derivatives. Protocatechuic
acid alkyl esters. J Agric Food Chem 58: 6986–6993.
19. Zeraik ML, Ximenes VF, Regasini LO, Dutra LA, Silva DH, et al. (2012) 49-
Aminochalcones as novel inhibitors of the chlorinating activity of myeloperox-
idase. Curr Med Chem 19: 5405–5413.
20. Castor LR, Locatelli KA, Ximenes VF (2010) Pro-oxidant activity of apocynin
radical. Free Radic Biol Med 48: 1636–1643.
21. dos Santo FJ, Ximenes VF, da Fonseca LM, de Faria Oliveira OM, Brunetti IL
(2005) Horseradish peroxidase-catalyzed oxidation of rifampicin: reaction rate
enhancement by co-oxidation with anti-inflammatory drugs. Biol Pharm Bull 28:
1822–1826.
41. Gaspar A, Garrido EM, Esteves M, Quezada E, Milhazes N, et al. (2009) New
insights into the antioxidant activity of hydroxycinnamic acids: Synthesis and
physicochemical characterization of novel halogenated derivatives. Eur J Med
Chem 44: 2092–2099.
22. Ximenes VF, Lopes MG, Petroˆnio MS, Regasini LO, Silva DH, et al. (2010)
Inhibitory effect of gallic acid and its esters on 2,2’-azobis(2-amidinopropane)-
hydrochloride (AAPH)-induced hemolysis and depletion of intracellular
glutathione in erythrocytes. J Agric Food Chem 58: 5355–5362.
23. Saito S, Kawabata J (2006) DPPH ( = 2,2-Diphenyl-1-picrylhydrazyl) radical-
scavenging reaction of protocatechuic acid ( = 3,4-Dihydroxybenzoic Acid):
difference in reactivity between acids and their esters. Helv Chim Acta 89: 1395–
1407.
42. Veitch NC (2004) Horseradish peroxidase: a modern view of a classic enzyme.
Phytochemistry 65: 249–259.
43. Kapiotis S, Sengoelge G, Hermann M, Held I, Seelos C, et al. (1997)
Paracetamol catalyzes myeloperoxidase-initiated lipid oxidation in LDL.
Arterioscler Thromb Vasc Biol 17: 2855–2860.
44. Ximenes VF, Pessoa AS, Padovan CZ, Abrantes DC, Gomes FH, et al. (2009)
Oxidation of melatonin by AAPH-derived peroxyl radicals: evidence of a pro-
oxidant effect of melatonin. Biochem Biophys Acta 1790: 787–792.
ˇ
24. Martins-Maciel ER, Campos LB, Salgueiro-Pagadigorria CL, Bracht A, Ishii-
Iwamoto EL (2013) Raloxifene affects fatty acid oxidation in livers from
ovariectomized rats by acting as a pro-oxidant agent. Toxicol Lett 217: 82–89.
´
´
´
45. Simic A, Manojlovic D, Segan D, Todorovic M (2007) Electrochemical behavior
and antioxidant and prooxidant activity of natural phenolics. Molecules 12:
2327–2340.
9
October 2014 | Volume 9 | Issue 10 | e110277